Table 4.
Association between UMMA, MCV, and treatment categories.
| Treatment groups | |||
|---|---|---|---|
| Nt (%) | Zt (%) | Nzt (%) | |
| UMMA (mg/24 hrs) | |||
| ≤15.76 | 8 (31%) | 22 (82%) | 27 (84%) |
| >15.76 | 18 (69%) | 5 (18) | 5 (16%) |
| Total | 26 | 27 | 32 |
| χ 2 (p value) | 1.842 (0.000) | ||
| MCV (fL) | |||
| ≤95 | 24 (92) | 15 (56) | 15 (41) |
| >95 | 2 (8) | 12 (46) | 15 (59) |
| Total | 26 | 27 | 32 |
| χ 2 (p value) | 1.842 (0.000) | ||
Treatment-naïve (Nt); Zidovudine based treatment group (Zt); non-zidovudine-based treatment group (NZt); urine methyl malonic acid (UMMA); mean cell volume (MCV); Chi-square value (χ 2).